Related Experiment Videos
Technology assessment in the Coronary Artery Surgery Study
E Burdick1, J Falotico-Taylor, J M Young
1Harvard School of Public Health.
Insights
The Coronary Artery Surgery Study (CASS) registry data primarily assessed coronary artery bypass graft surgery but also identified cardiovascular disease risk factors and evaluated diagnostic technologies. Quality of life and cost data enhance its value for technology assessment.
Area of Science:
- Cardiovascular Surgery
- Health Technology Assessment
- Clinical Registry Analysis
Background:
- The Coronary Artery Surgery Study (CASS) registry contains extensive data on patients undergoing coronary artery bypass graft surgery.
- Technology assessment is crucial for evaluating the efficacy and impact of medical interventions.
Purpose of the Study:
- To analyze the utilization of CASS registry data for technology assessment purposes.
- To explore the diverse applications of CASS data beyond its original scope.
- To highlight the value of incorporating quality of life and cost data into technology assessments.
Main Methods:
- Review of 26 technology assessment articles derived from the CASS registry.
- Analysis of how CASS data were applied to evaluate coronary artery bypass graft surgery.
- Examination of studies using CASS data for risk factor identification, diagnostic technology testing, and process evaluation.
Main Results:
- Most CASS technology assessment articles focused on evaluating coronary artery bypass graft surgery.
- CASS data were also leveraged to identify cardiovascular disease risk factors.
- The registry data supported the evaluation of diagnostic technologies and technological processes.
Conclusions:
- The CASS registry has been instrumental in assessing coronary artery bypass graft surgery technology.
- The versatility of CASS data extends to risk factor identification and diagnostic technology evaluation.
- Integrating quality of life and cost data significantly enhances the utility of the CASS registry for ongoing technology assessment.
Abstract:
The majority of the 26 technology assessment articles from the Coronary Artery Surgery Study (CASS) follow the original purpose of the registry and evaluate the therapeutic capabilities of coronary artery bypass graft surgery. However, these registry data have also been used to identify risk factors for cardiovascular disease, to test diagnostic technologies, and to evaluate technological processes. Consideration of quality of life issues and the availability of cost data provide valuable additions to the continued use of the CASS for technology assessment.